The world knee and hip reconstruction market was estimated at over $14 billion in 2011, and expected to grow at a CAGR of 4.7 percent upto 2016. The market is characterized by a wide range of options, price variation and the elective nature of the procedure makes it particularly sensitive to economic trends. More 75 percent of the market is accounted for by developed economies; however highest growth rates are in emerging markets particularly China and India. The largest product segments are cemented knee and hip implants. Factors driving the market inclue burgeoning rates of age-related conditions like osteoarthritis and osteoporosis, obesity-related conditions like diabetes that lead to peripheral neuropathies and sports-related injuries. A major driver in the mature markets has been the emergence of a younger patient population looking for high-functioning, longer-lasting technologies. Factors restraininbg the market include: Economic slowdown; ASPs are being slashed to more affordable rates, regulatory impacts (recalls, medical device alerts and surveillance by joint registries in N. America and Europe); the hip market is mature in the US, W. Europe and Japan; cultural aversion to invasive procedures in most Asian countries and access to trained surgeons. Government sponsored reimbursement is being scaled back to increase fiscal efficiency. New companies find enormously high entry barriers that include both technology and regulatory hurdles. Technology trends – materials (porous/ trabecular, antibiotic infused, more durable plastics like heavily cross-linked or ultra-high molecular weight polyethylene, graphitic surfaces that improve articulation, new combinations like ceramic on metal); designs (modular, gender and race-specific, patient-customized); fixation options now include hybrid implants that have cemented and cement-less components. Robotic surgery is optimizing precision of implantation while MIS devices are facilitating less traumatic surgery. Leading players include: Zimmer, DePuy, Stryker, Smith and Nephew and Biomet. Other significant players include Aesculap, and Wright Medical among others. Niche players with innovative products include Mako Surgical, BioPro Inc., CeramTec, ConfroMIS, and Corin Group among others.

1. Orthopedic (Hip and Knee)
Reconstruction Devices Markets
Worldwide
Report Highlights
March 2012

2. Report Benefits
This report can help in:
• Assessing the market for Hip and Knee Reconstruction,
growth segments, and growth regions.
• Understanding market drivers and restraints, market
segmentation, and competitive segmentation.
• Strategic planning and competitive strategy.
• Identifying opportunities for partnerships and alliances.
© 2012 Marketstrat, Inc., All Rights Reserved 2

3. Key Takeaways
• The world knee and hip reconstruction market was estimated at over $14 billion in 2011, and expected to grow at a CAGR of
4.7 percent up to 2016. The largest product segments are cemented knee and hip implants.
• Key Drivers: Burgeoning rates of age-related conditions like osteoarthritis and osteoporosis, obesity-related conditions like
diabetes that lead to peripheral neuropathies and sports-related injuries. A major driver in the mature markets has been the
emergence of a younger patient population looking for high-functioning, longer-lasting technologies.
• Key restraints: Economic slowdown ; ASPs are being slashed to more affordable rates, regulatory impacts (recalls, medical
device alerts and surveillance by joint registries in N. America and Europe); the hip market is mature in the US, W. Europe
and Japan; cultural aversion to invasive procedures in most Asian countries and access to trained surgeons. Government
sponsored reimbursement is being scaled back to increase fiscal efficiency. New companies find enormously high entry
barriers that include both technology and regulatory hurdles.
• Technology trends: Materials (porous/ trabecular, antibiotic infused, more durable plastics like heavily cross-linked or ultra-
high molecular weight polyethylene, graphitic surfaces that improve articulation, new combinations like ceramic on metal);
designs (modular, gender and race-specific, patient-customized); fixation options now include hybrid implants that have
cemented and cement-less components. Robotic surgery is optimizing precision of implantation while MIS devices are
facilitating less traumatic surgery.
• Leaders: Zimmer, DePuy, Stryker, Smith and Nephew and Biomet. Other significant players include Aesculap, and Wright
Medical among others.
• Innovative Niche Players: Mako Surgical, BioPro Inc., CeramTec, ConfroMIS, and Corin Group among others.
© 2012 Marketstrat, Inc., All Rights Reserved 3

4. Sample Data Table
© 2012 Marketstrat, Inc., All Rights Reserved 4

5. Sample Data Table
© 2012 Marketstrat, Inc., All Rights Reserved 5

6. Sample Data Chart
© 2012 Marketstrat, Inc., All Rights Reserved 6

7. Report Stats
Category Detail
Regions Covered United States; Canada; LATAM, Germany, France, UK, Italy, Japan, China, India;
Rest of the World (ROW)
Product/Market Segments •Knee Reconstruction/ Arthroplasty
o Total knee implants and partial (unicondylar)
o By Fixation – cemented, cementless and hybrid
o By Bearing-Type – fixed, mobile
o Revision
•Hip Reconstruction/ Arthroplasty
o Total hip reconstruction implants and Partial (unipolar, bipolar )
o By Fixation – cemented, cementless and hybrid
o By Material – metal-on-polyethylene, metal-on-metal, ceramic-
on-polyethylene and ceramic-on-ceramic
o Revision
o Hip Resurfacing
Company Profiles 53 Companies
Market Estimates/ Forecasts 2010-2016
Report Code 329-12
Price $3995 (single-user license); $7990 (corporate license)
No. of Pages 326 pages; 171data tables; 169 charts
Publication Date March 2012
© 2012 Marketstrat, Inc., All Rights Reserved 7

8. About Us
Marketstrat specializes in Medical Market Research. We assist companies
with market, technology, and best practice strategies & intelligence,
through a unique combination of published reports, solutions, and
services.
Our strengths include: a deep understanding of the medical devices value
chain, state-of-the-art data collection tools, and a robust research
methodology.
4695 Chabot Drive, Suite 200
Pleasanton, CA 94588, USA.
Email : info@marketstrat.com
Phone: 925-263-4455
Fax: 925-263-4456
www.marketstrat.com
© 2012 Marketstrat, Inc., All Rights Reserved 8

9. © 2012 Marketstrat, Inc., All Rights Reserved 9